Suit Alleges Biotech Firm Lied About FDA Trials

Law360, New York (June 11, 2007, 12:00 AM EDT) -- Trouble continues to mount for the biotechnology company Dendreon Corp. since it announced in May that the U.S. Food and Drug Administration asked for more information regarding its advanced prostate cancer drug, Provenge. At least three securities lawsuits have been filed, two coming in the last week.

One lawsuit, filed Wednesday in the U.S. District Court for the Western District of Washington, alleges that Washington-based Dendreon Corp. and some of its officers and directors were not forthcoming about the approval process for its drug.

The suit...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.